Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2001, 47, 75-79

https://doi.org/10.14712/fb2001047020075

Preventive Effect of Indomethacin and Melatonin on 7,12-dimethylbenz/a/anthracene-Induced Mammary Carcinogenesis in Female Sprague-Dawley Rats. A Preliminary Report

K. Môciková-Kalická, B. Bojková, E. Adámeková, M. Mníchová-Chamilová, P. Kubatka, Eva Ahlersová, I. Ahlers

Institute of Animal Physiology, Faculty of Science, P. J. Šafárik University, Košice, Slovakia

Received August 28, 2000
Accepted December 21, 2000

References

1. Ahlersová, E., Ahlers, I., Kubatka, P., Bojková, B., Môciková, K., Gajdošová, Š., Onderková, H. M. (2000) Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats. Folia Biol. (Praha) 46, 69-72.
2. Bayer, B. M., Kruth, H. S., Vaughan, M., Beaven, M. A. (1979) Arrest of cultured cells in the G1 phase of cell cycle by indomethacin. J. Pharmacol. Exp. Ther. 210, 106-111. <https://doi.org/10.1016/S0022-3565(25)31715-5>
3. Bojková, B., Kubatka, P., Môciková, K., Mníchová, M., Ahlersová, E., Ahlers, I. (2000) Effect of retinyl acetate and melatonin on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Folia Biol. (Praha) 46, 73-76.
4. Cohen, L. A., Karmali, R. A. (1984) Endogenous prostaglandin production by established cultures of neoplastic rat mammary epithelial cells. In Vitro 20, 119-126. <https://doi.org/10.1007/BF02626652>
5. Cos, S., Sánchez-Barceló, E. J. (2000) Melatonin and mammary pathological growth. Front. Neuroendocrinol. 21, 133-170. <https://doi.org/10.1006/frne.1999.0194>
6. Droller, M. J., Permann, P., Schneider, M. U. (1978) Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol. 39, 154-164. <https://doi.org/10.1016/0008-8749(78)90090-4>
7. Fosslien, E. (2000) Molecular pathology of cyclooxygenase-2 in neoplasia. Ann. Clin. Lab. Sci. 30, 3-22.
8. Fulton, A. M. (1984) Effect of indomethacin on the growth of cultured mammary tumors. Int. J. Cancer 33, 375-379. <https://doi.org/10.1002/ijc.2910330316>
9. Golab, J., Kozar, K., Kamiński, R., Czajka, A., Marczak, M., Świtaj, T., Giermasz, A., Stoklosa, T., Lasek, W., Zagozdzon, R., Mucha, K., Jakóbisiak, M. (2000) Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice. Life Sci. 66, 1223-1230. <https://doi.org/10.1016/S0024-3205(00)00427-6>
10. Hill, S. M., Blask, D. E. (1988) Effect of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48, 6121-6126.
11. Kubatka, P., Bojková, B., Môciková-Kalická, K., Mníchová-Chamilová, M., Adámeková, E., Ahlers, I., Ahlersová, E., Čermáková, M. (2001) Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz/a/anthracene, respectively, in female Sprague-Dawley rats. Folia Biol. (Praha) 47, 5-10.
12. Maestroni, J. M. C., Conti, A., Lissoni, P. (1994) Colony-stimulating activity and hematopoetic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. Cancer Res. 54, 4740-4748.
13. Marnett, L. J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52, 5575-5589.
14. McCormick, D. L., Madigan, M. J., Moon, R. C. (1985) Modulation of mammary carcinogenesis by indomethacin. Cancer Res. 45, 1803-1808.
15. Môciková, K., Mníchová, M., Kubatka, P., Bojková, B., Ahlers, I., Ahlersová, E. (2000) Mammary carcinogenesis induced in Wistar:Han rats by the combination of ionizing radiation and dimethylbenz/a/anthracene: prevention with melatonin. Neoplasma 47, 227-229.
16. Noguchi, M., Tanyia, T., Koyasaki, N., Kumaki, T., Miyazaki, I., Mizukami, Y. (1991) Effects of the prostaglandin synthetase inhibitor indomethacin on tumorigenesis, tumor proliferation, cell kinetics, and receptors contents of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in Sprague-Dawley rats fed a high- or low-fat diet. Cancer Res. 51, 2683-2689.
17. Noguchi, M., Erashi, M., Miyazaki, I., Tanaka, M., Sasaki, T. (1995) Effects of indomethacin with or without linoleic acid on human breast cancer cells in vitro. Prostaglandins Leukot. Essent. Fatty Acids 52, 381-386. <https://doi.org/10.1016/0952-3278(95)90065-9>
18. Rato, A. G., Pedrero, J. G., Martinez, M. A., del Rio, B., Lazo, P. S., Ramos, S. (1999) Melatonin blocks the activation of estrogen receptor for DNA binding. FASEB J. 13, 857-868. <https://doi.org/10.1096/fasebj.13.8.857>
19. Reiter, R. J. (1995) Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front. Neuroendocrinol. 16, 383-415. <https://doi.org/10.1006/frne.1995.1014>
20. Rita, M., Young, I. (1994) Eicosanoids and the immunology of cancer. Cancer Met. Rev. 13, 337-348.
21. Satch, K. (1978) Serum lipid peroxide in cerebrovascular disorder determined by a new colorimetric method. Clin. Chim. Acta 90, 37-43.
22. Sato, M., Narisawa, T., Sano, M., Takahasi, T., Goto, A. (1983) Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin. J. Cancer Res. Clin. Oncol. 106, 21-26. <https://doi.org/10.1007/BF00399893>
23. Sivarajah, K., Lasker, J. M., Eling, T. E. (1981) Prostaglandin synthetase-dependent cooxidation of (+/-)-benzo(a)pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. Cancer Res. 41, 1834-1839.
24. Tripathi, S. C., Vosseller, K. A., McCormick, D. L. (1996) Arachidonic acid metabolism and cell proliferation in rat mammary carcinoma cells treated with indomethacin. Biochem. Biophys. Acta 1316, 5-7.
25. Tsuji, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., DuBois, R. N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 703-716. <https://doi.org/10.1016/S0092-8674(00)81433-6>
26. Zhao, Y., Agarwal, V. R., Mendelson, C. R., Simpson, E. R. (1996) Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2, via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137, 5739-5742. <https://doi.org/10.1210/endo.137.12.8940410>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive